Intensive care support and clinical outcomes of patients with Ebola virus disease (EVD) in West Africa
Purpose We investigate the impact on outcome of different levels of supportive treatment in Ebola virus disease (EVD). The NGO EMERGENCY delivered care sequentially at two Ebola Treatment Centres (ETC) in Sierra Leone: first at Lakka (fluids, symptomatic, antibiotic, antimalaria treatment, and hospital level medical care), and thereafter in Goderich, adding organ support in the only African ETC with an equipped and staffed intensive care unit (ETC-ICU). Methods The primary outcome in this retrospective cohort study was in-ETC mortality. Secondarily, we used multivariable logistic regression to investigate the independent impact of the IC on mortality by comparing patients in two ETCs, adjusting for potential confounders, including the viral load (base-10 logarithm in copies/ml) (LVL), modelled as a piecewise linear function. Mortality was plotted versus LVL. Confidence bands were constructed by a bootstrap technique. The number of hospital-free days within 28 was computed to assess the burden of EVD. Results Data from 229 EVD patients were analysed (123 in Lakka, 106 in Goderich). Crude analysis showed a non-statistically significant difference in mortality (57.7% in Lakka vs 50.0% in Goderich; p = 0.19). Age and LVL were associated with mortality. Adjusted mortality was lower at the Goderich ICU-ETC (p = 0.055). This difference was observed with 80% confidence for patients with LVL between 7.5 and 8.5 copies/ml. Hospital-free days (of 28 days) were greater (7.7 vs 5.5; p = 0.03) for patients treated in the ICU-ETC. Conclusions Provision of critical care to patients with EVD is feasible in resource-limited settings and was associated with improved survival and less time in hospital..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
---|---|
Enthalten in: |
Intensive care medicine - 44(2018), 8 vom: 30. Juli, Seite 1266-1275 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Langer, Martin [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
Ebola virus disease |
---|
Anmerkungen: |
© The Author(s) 2018 |
---|
doi: |
10.1007/s00134-018-5308-4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2024527728 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC2024527728 | ||
003 | DE-627 | ||
005 | 20230516172523.0 | ||
007 | tu | ||
008 | 200820s2018 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1007/s00134-018-5308-4 |2 doi | |
035 | |a (DE-627)OLC2024527728 | ||
035 | |a (DE-He213)s00134-018-5308-4-p | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
082 | 0 | 4 | |a 610 |q VZ |
100 | 1 | |a Langer, Martin |e verfasserin |0 (orcid)0000-0002-8496-1620 |4 aut | |
245 | 1 | 0 | |a Intensive care support and clinical outcomes of patients with Ebola virus disease (EVD) in West Africa |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a © The Author(s) 2018 | ||
520 | |a Purpose We investigate the impact on outcome of different levels of supportive treatment in Ebola virus disease (EVD). The NGO EMERGENCY delivered care sequentially at two Ebola Treatment Centres (ETC) in Sierra Leone: first at Lakka (fluids, symptomatic, antibiotic, antimalaria treatment, and hospital level medical care), and thereafter in Goderich, adding organ support in the only African ETC with an equipped and staffed intensive care unit (ETC-ICU). Methods The primary outcome in this retrospective cohort study was in-ETC mortality. Secondarily, we used multivariable logistic regression to investigate the independent impact of the IC on mortality by comparing patients in two ETCs, adjusting for potential confounders, including the viral load (base-10 logarithm in copies/ml) (LVL), modelled as a piecewise linear function. Mortality was plotted versus LVL. Confidence bands were constructed by a bootstrap technique. The number of hospital-free days within 28 was computed to assess the burden of EVD. Results Data from 229 EVD patients were analysed (123 in Lakka, 106 in Goderich). Crude analysis showed a non-statistically significant difference in mortality (57.7% in Lakka vs 50.0% in Goderich; p = 0.19). Age and LVL were associated with mortality. Adjusted mortality was lower at the Goderich ICU-ETC (p = 0.055). This difference was observed with 80% confidence for patients with LVL between 7.5 and 8.5 copies/ml. Hospital-free days (of 28 days) were greater (7.7 vs 5.5; p = 0.03) for patients treated in the ICU-ETC. Conclusions Provision of critical care to patients with EVD is feasible in resource-limited settings and was associated with improved survival and less time in hospital. | ||
650 | 4 | |a Ebola virus disease | |
650 | 4 | |a Intensive care | |
650 | 4 | |a Multiple organ failure | |
650 | 4 | |a Health-care in resource limited countries | |
700 | 1 | |a Portella, Gina |4 aut | |
700 | 1 | |a Finazzi, Stefano |4 aut | |
700 | 1 | |a Chatenoud, Liliane |4 aut | |
700 | 1 | |a Lanini, Simone |4 aut | |
700 | 1 | |a Vairo, Francesco |4 aut | |
700 | 1 | |a Fowler, Robert |4 aut | |
700 | 1 | |a Miccio, Rossella |4 aut | |
700 | 1 | |a Ippolito, Giuseppe |4 aut | |
700 | 1 | |a Bertolini, Guido |4 aut | |
700 | 1 | |a Strada, Gino |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Intensive care medicine |d Springer Berlin Heidelberg, 1977 |g 44(2018), 8 vom: 30. Juli, Seite 1266-1275 |w (DE-627)129271047 |w (DE-600)80387-X |w (DE-576)014461633 |x 0342-4642 |7 nnns |
773 | 1 | 8 | |g volume:44 |g year:2018 |g number:8 |g day:30 |g month:07 |g pages:1266-1275 |
856 | 4 | 1 | |u https://doi.org/10.1007/s00134-018-5308-4 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_267 | ||
912 | |a GBV_ILN_2018 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4219 | ||
912 | |a GBV_ILN_4277 | ||
951 | |a AR | ||
952 | |d 44 |j 2018 |e 8 |b 30 |c 07 |h 1266-1275 |